logo
logo
Sign in

Precision Oncology Market, Revenue Share, Key Growth Trends, Major Players, and Forecast, 2020–2027

avatar
jhon tanison

 

The advancement in healthcare is beneficial for patients, the pharmaceutical industry, and society.

Market Size – USD 49.98 Billion in 2019, Market Growth - CAGR of 9.9%, Market Trends – Improvement and advancement in cancer biology.

The global Precision Oncology market is forecast to reach USD 99.72 Billion by 2027, according to a new report by Reports and Data. Precision oncology categories, recent advances in cancer care have been closely associated with genomic medicine. Knowing the genetic mutations of unique tumors holds the promise of giving practitioners a higher capacity to command specific prescriptions to fight specific tumors types. Although, only a few tumors and tumor types have been correlated with specific genetic mutations. In some forms of breast cancer, doctors instantly have years of expertise in genomic analysis to determine the most appropriate methods for their patients.

Physicians immediately can use DNA testing to look for the mutation of the gene; meanwhile, women with a family story of breast or ovarian cancer. Additionally, the combination of big data healthcare organizations with pharma & biotech corporations is likely to support market growth. On the other hand, the lack of awareness about the possible applications of precision medication and the compensation policies and regulatory framework is expected to hamper the market extension.

 

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3353

 

The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.

 

Key companies operating in the market and profiled in the report include:

Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc. NeoGenomics, Novartis AG, Pfizer Inc., QIAGEN, Tepnel Pharma Services, Teva Pharmaceuticals Industries Ltd, among others.

 

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3353

 

The Precision Oncology market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.

 

Segments Covered in the report

End-user Outlook (Revenue, USD Billion; 2017-2027)

  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Diagnostic Companies
  • Healthcare Data Companies

Technology Type Outlook (Revenue, USD Million; 2017-2027)

  • Big data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companies Diagnostics

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Consumable
  • Instruments
  • Services

 

 

Key Regions Analyzed in the Report include:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

 

To know more about the report @ https://www.reportsanddata.com/report-detail/precision-oncology-market

 

Furthermore, it consists information about individual segment of the Precision Oncology market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.

 

Further key findings from the report suggest

  • The global Precision Oncology market accounted for USD 49.98 billion in 2019 and is expected to grow at a CAGR of 9.9% from 2019 to 2027.
  • The Application is anticipated to reach USD 22.33 billion by 2027 and is expected to grow at a high rate over the forecast period.
  • The End-user segment dominated the market in 2019, with an estimated USD 99.72 billion.
  • The Biotechnology companies are the largest segment and are estimated to generate revenue of over USD 43.08 billion by 2027.
  • Demand for Precision oncology in defense is anticipated to witness moderate growth over the forecast period.
  • North America is expected to be an active region over the forecast period. Numerous enterprises and several new players within and have been investing in advanced sensor manufacturing. The regional market is expected to exhibit a CAGR of 12.7% over the forecast period.

 

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3353

 

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.

 

 Browse More Reports:

Peptide Cancer Vaccine Market

Purified Human Proteins Market

 

 

 

collect
0
avatar
jhon tanison
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more